[Diagnosis by recombinant DNA techniques and clinical features of familial amyloid polyneuropathy]

T Harada1

  • 1Department of Internal Medicine, Hiroshima University School of Medicine, Japan.

No to Shinkei = Brain and Nerve
|July 1, 1988
PubMed

Insights

Familial amyloid polyneuropathy (FAP) diagnosis is advanced by DNA testing, identifying a specific prealbumin variant linked to Andrade type FAP. This genetic analysis correlates with distinct clinical presentations in Japanese pedigrees.

Area of Science:

  • Genetics
  • Neurology
  • Biochemistry

Context:

  • Familial amyloid polyneuropathy (FAP) is a hereditary disorder.
  • A specific prealbumin variant (Val30Met) is associated with Andrade type FAP.
  • Recombinant DNA techniques offer new diagnostic possibilities.

Purpose:

  • To conduct DNA diagnosis for familial amyloid polyneuropathy (FAP) in Japanese pedigrees.
  • To correlate genetic findings with clinical manifestations.
  • To investigate the utility of restriction fragment length polymorphism (RFLP) analysis for FAP diagnosis.

Summary:

  • DNA diagnosis was performed on 30 individuals from FAP pedigrees in Nagano and Hiroshima Prefectures.
  • The study identified a prealbumin variant (Val30Met) using Nsi 1 and Bal 1 restriction enzymes.
  • Clinical features were compared with genetic findings, distinguishing between Andrade type FAP and a variant observed in Iiyama City (Iiyama type FAP).

Impact:

  • Establishes a DNA-based diagnostic method for FAP.
  • Differentiates clinical subtypes of FAP based on genetic markers.
  • Provides insights into the genetic basis and clinical heterogeneity of FAP in Japan.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...